Posted in | News | 3D Printing

Microfabrica to Participate in Panel Discussion on 3D Printing at SEMICON West 2014

Microfabrica, a leader in advanced additive manufacturing (AM) for the aerospace, medical device and semiconductor industries, announced today that the Company has been invited to discuss its proprietary technology at SEMICON West 2014 in San Francisco.

Microfabrica will participate in a panel discussion, 3D Printing: Science Fiction or the Next Industrial Revolution? The panel is part of a TechXPOT session on breakthrough technologies and will take place from 10:30 am - 12:30 pm on July 10, 2014. Microfabrica, the only company with a high volume production, micro-scale AM process, will discuss commercial applications for its technology in the semiconductor industry.

Microfabrica has leveraged its AM platform to establish global leadership in the fabrication of micro electrical contacts for the most advanced IC test applications. The Company's unique process allows for different metals to be combined into micro-composite structures that outperform any single metal or alloy. Micro-composites utilize best-in-class metals to enable optimal mechanical and electrical performance for IC test probes. This same capability has broad application in areas of thermal management and sensor packaging. Microfabrica will cover these applications, as well as its AM capabilities during its presentation.

"The science fiction around 3D printing is that the technology will soon be mature enough to print an entire jet engine," said Eric Miller, CEO. "Point of fact, for 3D printing to reach its full potential and become part of the next industrial revolution, it has to be practical as a high volume production solution. Microfabrica is leading this transformation, having shipped over 50 million commercial devices since our introduction in 2009."

Like 3D printing, Microfabrica manufactures 3-dimensional objects in layers directly from a digital model. This capability allows for unlimited design flexibility and eliminates the need for assembly. Unlike rapid prototyping, however, the technology is a commercial production solution. Microfabrica exploits the semi-conductor manufacturing paradigm to achieve high volume production with extreme precision at a micro scale. Thousands of devices are simultaneously manufactured on a single wafer. Further, Microfabrica's technology employs chemically pure, fully dense metals to produce robust commercial devices.

Who:
Microfabrica

What:
SEMI WEST 2014 TechXPOT South "3D Printing: Science Fiction or the Next Industrial Revolution?" / "Advanced Additive Manufacturing of Micro, Metal Composite Structures"

When:
July 10, 2014; 10:30am-12:30pm (panel) / 10:50am-11:10am (Microfabrica)

Where:
Moscone Center, San Francisco, CA

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Microfabrica. (2019, February 08). Microfabrica to Participate in Panel Discussion on 3D Printing at SEMICON West 2014. AZoM. Retrieved on December 03, 2024 from https://www.azom.com/news.aspx?newsID=41847.

  • MLA

    Microfabrica. "Microfabrica to Participate in Panel Discussion on 3D Printing at SEMICON West 2014". AZoM. 03 December 2024. <https://www.azom.com/news.aspx?newsID=41847>.

  • Chicago

    Microfabrica. "Microfabrica to Participate in Panel Discussion on 3D Printing at SEMICON West 2014". AZoM. https://www.azom.com/news.aspx?newsID=41847. (accessed December 03, 2024).

  • Harvard

    Microfabrica. 2019. Microfabrica to Participate in Panel Discussion on 3D Printing at SEMICON West 2014. AZoM, viewed 03 December 2024, https://www.azom.com/news.aspx?newsID=41847.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.